Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Meissner, WG"'
Publikováno v:
Aktuelle Neurologie; 20240101, Issue: Preprints
Autor:
Apartis E, Blancher A, Meissner WG, Guyant-Maréchal L, Maltête D, De Broucker T, Legrand AP, Bouzenada H, Thanh HT, Sallansonnet-Froment M, Wang A, Tison F, Roué-Jagot C, Sedel F, Charles P, Whalen S, Héron D, Thobois S, Poisson A, Lesca G
Publikováno v:
Neurology; 10/30/2012, Vol. 79 Issue 18, p1898-1907, 10p
Autor:
Kalia LV; Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada., Berg D; Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel and Christian Albrechts-University of Kiel, Kiel, Germany., Kordower JH; ASU-Banner Neurodegenerative Disease Research Center, Tempe, Arizona, USA.; School of Life Sciences, Arizona State University, Tempe, Arizona, USA., Shannon KM; Department of Neurology, University of Wisconsin School of Public Health, Madison, Wisconsin, USA., Taylor JP; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Cardoso F; Movement Disorders Unit, Neurology Service, Internal Medicine Department, The Federal University of Minas Gerais, Belo Horizonte, Brazil., Goldman JG; Barrow Neurological Institute, Phoenix, Arizona, USA.; JPG Enterprises LLC, Chicago, Illinois, USA., Jeon B; BJ Center for Comprehensive Parkinson Care and Rare Movement Disorders, Chung-Ang University Health Care System, Hyundae Hospital, Namyangju-si, South Korea., Meissner WG; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc, Bordeaux, France.; Univ. Bordeaux, CNRS, IMN, UMR5293, Bordeaux, France.; Department of Medicine, University of Otago, Christchurch, and New Zealand Brain Research Institute, Christchurch, New Zealand., Tijssen MAJ; Department of Neurology, Expertise Centre Movement Disorders, University Medical Centre Groningen, Groningen, The Netherlands., Burn DJ; Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Fung VSC; Movement Disorders Unit, Department of Neurology, Westmead Hospital, Westmead, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2024 Oct; Vol. 39 (10), pp. 1710-1715. Date of Electronic Publication: 2024 Sep 09.
Autor:
Pigott JS; Clinical Neurosciences, Queen Square Institute of Neurology, University College London, Royal Free Hospital, Rowland Hill Street, London, NW3 2PF, UK., Armstrong M; Centre for Ageing Population Studies, Research Department of Primary Care and Population Health, University College London, London, UK.; Centre For Psychiatry and Mental Health, Queen Mary University of London, London, UK., Davies N; Centre for Ageing Population Studies, Research Department of Primary Care and Population Health, University College London, London, UK., Davis D; MRC Unit for Lifelong Health and Ageing, University College London, London, UK., Bloem BR; Donders Institute for Brain, Cognition and Behavior, Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands., Lorenzl S; Institute for Palliative Care, Paracelsus Medical University, Salzburg, Austria.; Department of Palliative Medicine, University Hospital, LMU Munich, Munich, Germany.; Department of Neurology and Palliative Care, University Hospital Agatharied, Hausham, Germany., Meissner WG; Service de Neurologie des Maladies Neurodégénératives, IMNc, IMN, UMR 5293, CHU de Bordeaux, Univ. de Bordeaux, CNRS, 33000, Bordeaux, France.; Dept. Medicine, University of Otago, Christchurch, and New Zealand Brain Research Institute, Christchurch, New Zealand., Odin P; Division of Neurology, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden.; Faculdade de Medicina, Instituto de Medicina Molecular João Lobo Antunes, Universidade de Lisboa, Lisboa, Portugal., Ferreira JJ; Dept. Medicine, University of Otago, Christchurch, and New Zealand Brain Research Institute, Christchurch, New Zealand., Dodel R; Department of Geriatric Medicine, University Duisburg Essen, Essen, Germany., Schrag A; Clinical Neurosciences, Queen Square Institute of Neurology, University College London, Royal Free Hospital, Rowland Hill Street, London, NW3 2PF, UK. a.schrag@ucl.ac.uk.
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2024 Sep; Vol. 33 (9), pp. 2439-2452. Date of Electronic Publication: 2024 Jun 18.
Autor:
Pigott JS; Queen Square Institute of Neurology, University College London, London, UK., Bloem BR; Donders Institute for Brain, Cognition and Behavior, Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands., Lorenzl S; Institute for Palliative Care, Paracelsus Medical University, Salzburg, Austria.; Department of Neurology and Palliative Care, University Hospital Agatharied, Hausham, Germany.; Institute of Nursing Science and Practice, Salzburg, Austria., Meissner WG; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc, NS-Park/FCRIN Network, Bordeaux, France.; Univ. Bordeaux, CNRS, IMN, UMR5293, Bordeaux, France.; Deptartment of Medicine, University of Otago, Christchurch, New Zealand.; New Zealand Brain Research Institute, Christchurch, New Zealand., Odin P; Division of Neurology, Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden., Ferreira JJ; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Portugal., Dodel R; Department of Geriatric Medicine, University Duisburg Essen, Essen, Germany., Schrag A; Queen Square Institute of Neurology, University College London, London, UK.
Publikováno v:
Journal of geriatric psychiatry and neurology [J Geriatr Psychiatry Neurol] 2024 Sep; Vol. 37 (5), pp. 355-367. Date of Electronic Publication: 2024 Jan 17.
Autor:
Krismer F; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. Electronic address: florian.krismer@i-med.ac.at., Fanciulli A; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria., Meissner WG; Centre Hospitalier Universitaire Bordeaux, Service de Neurologie des Maladies Neurodégénératives, Institut des Maladies Neurodégénératives Clinique, French Clinical Research Network for Parkinson's Disease and Movement Disorders, Bordeaux, France; Université de Bordeaux, Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Unité Mixte de Recherche 5293, Bordeaux, France; Department of Medicine, University of Otago, Christchurch, New Zealand; New Zealand Brain Research Institute, Christchurch, New Zealand., Coon EA; Mayo Clinic, Department of Neurology, Rochester, MN, USA., Wenning GK; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
Publikováno v:
The Lancet. Neurology [Lancet Neurol] 2024 Dec; Vol. 23 (12), pp. 1252-1266.
Autor:
Saulnier T; Bordeaux Population Health Research Center, Inserm U1219, University of Bordeaux, Bordeaux, France., Fabbri M; MSA French Reference Center, University Hospital Toulouse, Toulouse, France.; Departments of Clinical Pharmacology and Neurosciences, University of Toulouse, CIC-1436, NeuroToul COEN Center, NS-Park/FCRIN Network, Toulouse University Hospital, Inserm U1048/1214, Toulouse, France., Le Goff M; Bordeaux Population Health Research Center, Inserm U1219, University of Bordeaux, Bordeaux, France., Helmer C; Bordeaux Population Health Research Center, Inserm U1219, University of Bordeaux, Bordeaux, France.; CIC1401-EC, Inserm, Bordeaux, France., Pavy-Le Traon A; MSA French Reference Center, University Hospital Toulouse, Toulouse, France.; Departments of Clinical Pharmacology and Neurosciences, University of Toulouse, CIC-1436, NeuroToul COEN Center, NS-Park/FCRIN Network, Toulouse University Hospital, Inserm U1048/1214, Toulouse, France., Meissner WG; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc, CRMR AMS, NS-Park/FCRIN Network, University of Bordeaux, CNRS, IMN, UMR5293, Bordeaux, France.; Department of Medicine, University of Otago, New Zealand Brain Research Institute, Christchurch, New Zealand., Rascol O; MSA French Reference Center, University Hospital Toulouse, Toulouse, France.; Departments of Clinical Pharmacology and Neurosciences, University of Toulouse, CIC-1436, NeuroToul COEN Center, NS-Park/FCRIN Network, Toulouse University Hospital, Inserm U1048/1214, Toulouse, France., Proust-Lima C; Bordeaux Population Health Research Center, Inserm U1219, University of Bordeaux, Bordeaux, France cecile.proust-lima@u-bordeaux.fr.; CIC1401-EC, Inserm, Bordeaux, France., Foubert-Samier A; Bordeaux Population Health Research Center, Inserm U1219, University of Bordeaux, Bordeaux, France.; CIC1401-EC, Inserm, Bordeaux, France.; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc, CRMR AMS, NS-Park/FCRIN Network, University of Bordeaux, CNRS, IMN, UMR5293, Bordeaux, France.
Publikováno v:
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2024 Aug 16; Vol. 95 (9), pp. 804-811. Date of Electronic Publication: 2024 Aug 16.
Autor:
Chia R; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA., Ray A; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA., Shah Z; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA., Ding J; Computational Biology Group, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA., Ruffo P; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA; Medical Genetics Laboratory, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy., Fujita M; Center for Translational & Computational Neuroimmunology, Department of Neurology, Columbia University Irving Medical Center and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, New York, NY, USA., Menon V; Center for Translational & Computational Neuroimmunology, Department of Neurology, Columbia University Irving Medical Center and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, New York, NY, USA., Saez-Atienzar S; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA., Reho P; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA., Kaivola K; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA., Walton RL; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA., Reynolds RH; NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London, UK; Great Ormond Street Institute of Child Health, Genetics and Genomic Medicine, University College London, London, UK; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK., Karra R; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA., Sait S; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA., Akcimen F; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA., Diez-Fairen M; Memory and Movement Disorders Units, Department of Neurology, University Hospital Mutua de Terrassa, Barcelona, Spain., Alvarez I; Memory and Movement Disorders Units, Department of Neurology, University Hospital Mutua de Terrassa, Barcelona, Spain., Fanciulli A; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Stefanova N; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Seppi K; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Duerr S; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Leys F; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Krismer F; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Sidoroff V; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Zimprich A; Department of Neurology, Medical University of Vienna, Vienna, Austria., Pirker W; Department of Neurology, Klinik Ottakring - Wilhelminenspital, Vienna, Austria., Rascol O; MSA French Reference Center and CIC-1436, Department of Clinical Pharmacology and Neurosciences, University of Toulouse, Toulouse, France., Foubert-Samier A; Service de Neurologie des Maladies Neurodégénératives, French Reference Center for MSA, NS-Park/FCRIN Network, CHU Bordeaux, Bordeaux, France., Meissner WG; Service de Neurologie des Maladies Neurodégénératives, French Reference Center for MSA, NS-Park/FCRIN Network, CHU Bordeaux, Bordeaux, France; University of Bordeaux, CNRS, IMN, UMR 5293, Bordeaux, France; Department of Medicine, University of Otago, and the New Zealand Brain Research Institute, Christchurch, New Zealand., Tison F; Service de Neurologie des Maladies Neurodégénératives, French Reference Center for MSA, NS-Park/FCRIN Network, CHU Bordeaux, Bordeaux, France; University of Bordeaux, CNRS, IMN, UMR 5293, Bordeaux, France., Pavy-Le Traon A; French Reference Center for MSA, Department of Neurosciences, Centre d'Investigation Clinique de Toulouse CIC1436, UMR 1048, Institute of Cardiovascular and Metabolic Diseases (I2MC), University Hospital of Toulouse, INSERM, Toulouse, France., Pellecchia MT; Neuroscience Section, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Salerno, Italy., Barone P; Neuroscience Section, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Salerno, Italy., Russillo MC; Neuroscience Section, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Salerno, Italy., Marín-Lahoz J; Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Institut d'Investigacions Biomèdiques Sant Pau (IIB-Sant Pau), Centro de Investigación en Red Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, Barcelona, Spain; Servicio de Neurología, Hospital Universitario Miguel Servet, Zaragoza, Spain., Kulisevsky J; Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Institut d'Investigacions Biomèdiques Sant Pau (IIB-Sant Pau), Centro de Investigación en Red Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, Barcelona, Spain., Torres S; Institut d'Investigacions Biomèdiques Sant Pau (IIB-Sant Pau), Centro de Investigación en Red Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, Barcelona, Spain., Mir P; Unidad de Trastornos del Movimiento Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Seville, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain; Departamento de Medicina Facultad de Medicina, Universidad de Sevilla, Seville, Spain., Periñán MT; Unidad de Trastornos del Movimiento Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Seville, Spain; Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University, London, UK., Proukakis C; Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology, London, UK., Chelban V; Department of Neuromuscular Diseases, University College London Queen Square Institute of Neurology, London, UK; The National Hospital for Neurology and Neurosurgery, London, UK., Wu L; Department of Neuromuscular Diseases, University College London Queen Square Institute of Neurology, London, UK., Goh YY; Department of Neuromuscular Diseases, University College London Queen Square Institute of Neurology, London, UK., Parkkinen L; Nuffield Department of Clinical Neurosciences, Oxford Parkinson's Disease Centre, University of Oxford, Oxford, UK., Hu MT; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK., Kobylecki C; Department of Neurology, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK., Saxon JA; Cerebral Function Unit, Manchester Centre for Clinical Neurosciences, Salfort, UK; Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Rollinson S; Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Garland E; Autonomic Dysfunction Center, Vanderbilt University Medical Center, Nashville, TN, USA., Biaggioni I; Autonomic Dysfunction Center, Vanderbilt University Medical Center, Nashville, TN, USA., Litvan I; Department of Neurosciences, University of California, San Diego, San Diego, CA, USA., Rubio I; Department of Neurosciences, University of California, San Diego, San Diego, CA, USA., Alcalay RN; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA; Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Kwei KT; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA., Lubbe SJ; Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Mao Q; Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA., Flanagan ME; Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, UT Health San Antonio, San Antonio, TX, USA; Department of Pathology, UT Health San Antonio, San Antonio, TX, USA., Castellani RJ; Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Khurana V; Ann Romney Center for Neurologic Disease, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Harvard Stem Cell Institute, Cambridge, MA, USA., Ndayisaba A; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria; Ann Romney Center for Neurologic Disease, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Calvo A; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy., Mora G; Istituti Clinici Scientifici Maugeri, IRCCS, Milan, Italy., Canosa A; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy., Floris G; Department of Neurology, University Hospital of Cagliari, Cagliari, Italy., Bohannan RC; Department of Neurobiology and Behavior, University of California, Irvine, Irvine, CA, USA., Moore A; Computational Biology Group, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA., Norcliffe-Kaufmann L; Department of Neurology, New York University School of Medicine, New York, NY, USA., Palma JA; Department of Neurology, New York University School of Medicine, New York, NY, USA., Kaufmann H; Department of Neurology, New York University School of Medicine, New York, NY, USA., Kim C; Molecular Neuropathology Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA., Iba M; Molecular Neuropathology Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA., Masliah E; Molecular Neuropathology Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA., Dawson TM; Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA; Neuroregeneration and Stem Cell Programs, Institute of Cell Engineering, Johns Hopkins University Medical Center, Baltimore, MD, USA; Department of Pharmacology and Molecular Science, Johns Hopkins University Medical Center, Baltimore, MD, USA; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University Medical Center, Baltimore, MD, USA., Rosenthal LS; Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA., Pantelyat A; Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA., Albert MS; Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA., Pletnikova O; Department of Pathology (Neuropathology), Johns Hopkins University Medical Center, Baltimore, MD, USA; Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Troncoso JC; Department of Pathology (Neuropathology), Johns Hopkins University Medical Center, Baltimore, MD, USA., Infante J; Neurology Service, University Hospital Marqués de Valdecilla-IDIVAL-UC-CIBERNED, Santander, Spain., Lage C; Neurology Service, University Hospital Marqués de Valdecilla-IDIVAL-UC-CIBERNED, Santander, Spain., Sánchez-Juan P; Neurology Service, University Hospital Marqués de Valdecilla-IDIVAL-UC-CIBERNED, Santander, Spain; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Madrid, Spain., Serrano GE; Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, USA., Beach TG; Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, USA., Pastor P; Genomics and Transcriptomics of Synucleinopathies, Neurosciences, The Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain; Unit of Neurodegenerative Diseases, Department of Neurology, University Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain., Morris HR; Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology, University College London, London, UK., Albani D; Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Clarimon J; Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; The Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain., Wenning GK; Autonomic Unit - Division of Neurobiology, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Hardy JA; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK; UK Dementia Research Institute of UCL, UCL Institute of Neurology, University College London, London, UK; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, University College London, London, UK; UCL Movement Disorders Centre, University College London, London, UK; Institute for Advanced Study, The Hong Kong University of Science and Technology, Hong Kong SAR, China., Ryten M; NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London, UK; Great Ormond Street Institute of Child Health, Genetics and Genomic Medicine, University College London, London, UK., Topol E; Scripps Research Translational Institute, Scripps Research, La Jolla, CA, USA., Torkamani A; Scripps Research Translational Institute, Scripps Research, La Jolla, CA, USA., Chiò A; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy; Institute of Cognitive Sciences and Technologies, C.N.R., Rome, Italy; Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy., Bennett DA; Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA., De Jager PL; Center for Translational & Computational Neuroimmunology, Department of Neurology, Columbia University Irving Medical Center and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, New York, NY, USA., Low PA; Department of Neurology, Mayo Clinic, Rochester, MN, USA., Singer W; Department of Neurology, Mayo Clinic, Rochester, MN, USA., Cheshire WP; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA., Wszolek ZK; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA., Dickson DW; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA., Traynor BJ; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA; Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA; RNA Therapeutics Laboratory, Therapeutics Development Branch, National Center for Advancing Translational Sciences, Rockville, MD, USA., Gibbs JR; Computational Biology Group, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA., Dalgard CL; Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Ross OA; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA; Department of Clinical Genomics, Mayo Clinic, Jacksonville, FL, USA., Houlden H; Department of Neuromuscular Diseases, University College London Queen Square Institute of Neurology, London, UK; The National Hospital for Neurology and Neurosurgery, London, UK., Scholz SW; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA; Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA. Electronic address: sonja.scholz@nih.gov.
Publikováno v:
Neuron [Neuron] 2024 Jul 03; Vol. 112 (13), pp. 2142-2156.e5. Date of Electronic Publication: 2024 May 02.
Autor:
Fabbri M; Department of Clinical Pharmacology and Neurosciences, Clinical Investigation Center CIC1436, Toulouse Parkinson Expert Centre, Toulouse NeuroToul Center of Excellence in Neurodegeneration (COEN), University of Toulouse 3, CHU of Toulouse, INSERM, Toulouse, France. margheritafabbrimd@gmail.com.; Service de Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France. margheritafabbrimd@gmail.com.; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France. margheritafabbrimd@gmail.com., Rousseau V; Department of Clinical Pharmacology, Clinical Investigation Center CIC1436, Centre Hospitalier Universitaire de Toulouse, Toulouse, France., Corvol JC; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Sorbonne Université, Institut du Cerveau, Paris Brain Institute, ICM, Inserm, CNRS, Paris, France.; Department of Neurology, Assistance Publique Hôpitaux de Paris, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France., Sommet A; Department of Clinical Pharmacology, Clinical Investigation Center CIC1436, Centre Hospitalier Universitaire de Toulouse, Toulouse, France., Tubach F; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié Salpêtrière, Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Unité de Recherche Clinique PSL-CFX, CIC-1901, F75013, Paris, France., De Rycke Y; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié Salpêtrière, Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Unité de Recherche Clinique PSL-CFX, CIC-1901, F75013, Paris, France., Bertille N; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié Salpêtrière, Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Unité de Recherche Clinique PSL-CFX, CIC-1901, F75013, Paris, France., Selvarasa Y; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Sorbonne Université, Institut du Cerveau, Paris Brain Institute, ICM, Inserm, CNRS, Paris, France.; Department of Neurology, Assistance Publique Hôpitaux de Paris, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France., Carvalho S; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Sorbonne Université, Institut du Cerveau, Paris Brain Institute, ICM, Inserm, CNRS, Paris, France.; Department of Neurology, Assistance Publique Hôpitaux de Paris, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France., Chaigneau V; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France., Brefel-Courbon C; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center CIC1436, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse NeuroImaging Center, Inserm, University of Toulouse 3, Toulouse, France., Ory-Magne F; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Service de Neurologie, Centre Hospitalier Universitaire, Toulouse, Université de Toulouse-Toulouse 3, INSERM, UMR1214 Toulouse NeuroImaging Centre 'TONIC,' Center of Excellence in Neurodegeneration (CoEN), NeuroToul, Parkinson Expert Center, Clinical Investigation Center CIC1436, Toulouse, France., Tessier S; Service de Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France., Tir M; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Department of Neurology, University Hospital of Amiens, Amiens, France., Bereau M; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Department of Neurology, University Hospital of Besançon, Besançon, France., Meissner WG; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc, NS-Park/FCRIN Network, 33000, Bordeaux, France.; Univ. Bordeaux, CNRS, IMN, UMR5293, 33000, Bordeaux, France.; Dept. Medicine, University of Otago, Christchurch, New Zealand.; New Zealand Brain Research, Christchurch, New Zealand., Thiriez C; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Department of Neurology and Parkinson Expert Centre, Caen University-Hospital, Caen, France., Marques A; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Neurology Department, Université Clermont Auvergne, EA7280 NPsy-Sydo, Clermont-Ferrand University Hospital, Clermont-Ferrand, France., Remy P; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Centre Expert Parkinson, Neurologie, CHU Henri Mondor, AP-HP, Equipe NPI, IMRB INSERM Et Faculté de Santé, Université Paris-Est Créteil, Créteil, France., Schneider V; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Département de Neurologie, Centre Hospitalier Universitaire François Mitterrand, Université de Bourgogne, Dijon, France., Moro E; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Unité des Troubles du Movement, Service de Neurologie, Coordinatrice du Pole PRENELE, CHU de Grenoble, Assesseur Relations Internationales, Faculté de Médécine, Université Grenoble Alpes, President Elect, European Academy of Neurology, Grenoble, France., Defebvre L; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Movement Disorders Department, Lille University, Inserm 1172, Lille, France., Houeto JL; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Department of Neurology, Limoges University Hospital, Inserm, U1094, EpiMaCT-Epidemiology of Chronic Diseases in Tropical Zone, 87042, Limoges Cedex 01, France., Prange S; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Hospices Civils de Lyon, Pierre Wertheimer Neurological Hospital, Expert Parkinson Center, Lyon University, Bron, France.; Université Claude Bernard Lyon 1, Faculté de Médecine et de Maïeutique Lyon Sud Charles Mérieux, Oullins, France.; Marc Jeannerod Institute for Cognitive Neuroscience, CNRS, UMR 5229, Bron, France., Eusebio A; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Movement Disorders Unit, Neurology Department, University Hospital of Marseille, Marseille, France., Geny C; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; EuroMov, Univ. Montpellier, Montpellier, France.; Department of Neurology, CHRU Montpellier, Montpellier, France., Frismand S; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Service de Neurologie, Centre Expert Parkinson, Centre Mémoire de Ressources et de Recherche de Lorraine, Hôpital Central Nancy, Nancy, France., Damier P; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Service de Neurologie, CHU Nantes, INSERM, CIC, 1413, Nantes, France., Reuther CG; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Department of Neurology, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France., Castelnovo G; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Department of Neurology, University Hospital of Nîmes, Nîmes, France., Benatru I; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Departement of Neurology, Poitiers University Hospital, INSERM, CHU de Poitiers, Centre d'Investigation Clinique CIC1402, Poitiers, France., De Maindreville AD; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Department of Neurology, Hôpital Maison Blanche, Reims, France., Drapier S; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Department of Neurology, Pontchaillou University Hospital, CIC INSERM 1414, Rennes, France., Maltête D; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Department of Neurology, Rouen University Hospital and University of Rouen, Rouen, France.; Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, CEP Rouen, INSERM U1239, Mont-Saint-Aignan, France., Lagha-Boukbiza O; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Rascol O; Department of Clinical Pharmacology and Neurosciences, Clinical Investigation Center CIC1436, Toulouse Parkinson Expert Centre, Toulouse NeuroToul Center of Excellence in Neurodegeneration (COEN), University of Toulouse 3, CHU of Toulouse, INSERM, Toulouse, France.; Service de Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France.; French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.
Publikováno v:
Journal of neural transmission (Vienna, Austria : 1996) [J Neural Transm (Vienna)] 2024 Jul; Vol. 131 (7), pp. 799-811. Date of Electronic Publication: 2024 Apr 05.
Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease.
Autor:
Aye WWT; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand., Stark MR; New Zealand Brain Research Institute Christchurch New Zealand., Horne KL; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand., Livingston L; New Zealand Brain Research Institute Christchurch New Zealand., Grenfell S; New Zealand Brain Research Institute Christchurch New Zealand., Myall DJ; New Zealand Brain Research Institute Christchurch New Zealand., Pitcher TL; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand., Almuqbel MM; New Zealand Brain Research Institute Christchurch New Zealand.; Radiology Holding Company New Zealand Christchurch New Zealand., Keenan RJ; New Zealand Brain Research Institute Christchurch New Zealand.; Radiology Holding Company New Zealand Christchurch New Zealand., Meissner WG; New Zealand Brain Research Institute Christchurch New Zealand.; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives IMNc, NS-Park/FCRIN Network Bordeaux France.; Univ. Bordeaux, CNRS, IMN Bordeaux France., Dalrymple-Alford JC; New Zealand Brain Research Institute Christchurch New Zealand.; School of Psychology, Speech and Hearing, University of Canterbury, Psychology Speech and Hearing Arts Road, Ilam Christchurch New Zealand., Anderson TJ; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.; Department of Neurology Canterbury District Health Board Christchurch New Zealand., Heron CL; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.; School of Psychology, Speech and Hearing, University of Canterbury, Psychology Speech and Hearing Arts Road, Ilam Christchurch New Zealand.; Department of Neurology Canterbury District Health Board Christchurch New Zealand., Melzer TR; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.; Radiology Holding Company New Zealand Christchurch New Zealand.; School of Psychology, Speech and Hearing, University of Canterbury, Psychology Speech and Hearing Arts Road, Ilam Christchurch New Zealand.
Publikováno v:
Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2024 Jun 22; Vol. 16 (2), pp. e12601. Date of Electronic Publication: 2024 Jun 22 (Print Publication: 2024).